Cargando…
Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock
INTRODUCTION: This prospective, randomized, controlled, experimental animal study looks at the effects of recombinant human activated protein C (rhAPC) on global hemodynamics and microcirculation in ovine acute lung injury (ALI) and septic shock, resulting from smoke inhalation injury. METHODS: Twen...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220026/ https://www.ncbi.nlm.nih.gov/pubmed/21110850 http://dx.doi.org/10.1186/cc9342 |
_version_ | 1782216933874073600 |
---|---|
author | Maybauer, Marc O Maybauer, Dirk M Fraser, John F Szabo, Csaba Westphal, Martin Kiss, Levente Horvath, Eszter M Nakano, Yoshimitsu Herndon, David N Traber, Lillian D Traber, Daniel L |
author_facet | Maybauer, Marc O Maybauer, Dirk M Fraser, John F Szabo, Csaba Westphal, Martin Kiss, Levente Horvath, Eszter M Nakano, Yoshimitsu Herndon, David N Traber, Lillian D Traber, Daniel L |
author_sort | Maybauer, Marc O |
collection | PubMed |
description | INTRODUCTION: This prospective, randomized, controlled, experimental animal study looks at the effects of recombinant human activated protein C (rhAPC) on global hemodynamics and microcirculation in ovine acute lung injury (ALI) and septic shock, resulting from smoke inhalation injury. METHODS: Twenty-one sheep (37 ± 2 kg) were operatively prepared for chronic study and randomly allocated to either the sham, control, or rhAPC group (n = 7 each). The control and rhAPC groups were subjected to insufflation of four sets of 12 breaths of cotton smoke followed by instillation of live Pseudomonas aeruginosa into both lung lobes, according to an established protocol. Healthy sham animals were not subjected to the injury and received only four sets of 12 breaths of room air and instillation of the vehicle (normal saline). rhAPC (24 μg/kg/hour) was intravenously administered from 1 hour post injury until the end of the 24-hour experiment. Regional microvascular blood flow was analyzed using colored microspheres. All sheep were mechanically ventilated with 100% oxygen, and fluid resuscitated with lactated Ringer's solution to maintain hematocrit at baseline levels. RESULTS: The rhAPC-associated reduction in heart malondialdehyde (MDA) and heart 3-nitrotyrosine (a reliable indicator of tissue injury) levels occurred parallel to a significant increase in mean arterial pressure and to a significant reduction in heart rate and cardiac output compared with untreated controls that showed a typical hypotensive, hyperdynamic response to the injury (P < 0.05). In addition, rhAPC significantly attenuated the changes in microvascular blood flow to the trachea, kidney, and spleen compared with untreated controls (P < 0.05 each). Blood flow to the ileum and pancreas, however, remained similar between groups. The cerebral blood flow as measured in cerebral cortex, cerebellum, thalamus, pons, and hypothalamus, was significantly increased in untreated controls, due to a loss of cerebral autoregulation in septic shock. rhAPC stabilized cerebral blood flow at baseline levels, as in the sham group. CONCLUSIONS: We conclude that rhAPC stabilized cardiovascular functions and attenuated the changes in visceral and cerebral microcirculation in sheep suffering from ALI and septic shock by reduction of cardiac MDA and 3-nitrotyrosine. |
format | Online Article Text |
id | pubmed-3220026 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32200262011-11-18 Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock Maybauer, Marc O Maybauer, Dirk M Fraser, John F Szabo, Csaba Westphal, Martin Kiss, Levente Horvath, Eszter M Nakano, Yoshimitsu Herndon, David N Traber, Lillian D Traber, Daniel L Crit Care Research INTRODUCTION: This prospective, randomized, controlled, experimental animal study looks at the effects of recombinant human activated protein C (rhAPC) on global hemodynamics and microcirculation in ovine acute lung injury (ALI) and septic shock, resulting from smoke inhalation injury. METHODS: Twenty-one sheep (37 ± 2 kg) were operatively prepared for chronic study and randomly allocated to either the sham, control, or rhAPC group (n = 7 each). The control and rhAPC groups were subjected to insufflation of four sets of 12 breaths of cotton smoke followed by instillation of live Pseudomonas aeruginosa into both lung lobes, according to an established protocol. Healthy sham animals were not subjected to the injury and received only four sets of 12 breaths of room air and instillation of the vehicle (normal saline). rhAPC (24 μg/kg/hour) was intravenously administered from 1 hour post injury until the end of the 24-hour experiment. Regional microvascular blood flow was analyzed using colored microspheres. All sheep were mechanically ventilated with 100% oxygen, and fluid resuscitated with lactated Ringer's solution to maintain hematocrit at baseline levels. RESULTS: The rhAPC-associated reduction in heart malondialdehyde (MDA) and heart 3-nitrotyrosine (a reliable indicator of tissue injury) levels occurred parallel to a significant increase in mean arterial pressure and to a significant reduction in heart rate and cardiac output compared with untreated controls that showed a typical hypotensive, hyperdynamic response to the injury (P < 0.05). In addition, rhAPC significantly attenuated the changes in microvascular blood flow to the trachea, kidney, and spleen compared with untreated controls (P < 0.05 each). Blood flow to the ileum and pancreas, however, remained similar between groups. The cerebral blood flow as measured in cerebral cortex, cerebellum, thalamus, pons, and hypothalamus, was significantly increased in untreated controls, due to a loss of cerebral autoregulation in septic shock. rhAPC stabilized cerebral blood flow at baseline levels, as in the sham group. CONCLUSIONS: We conclude that rhAPC stabilized cardiovascular functions and attenuated the changes in visceral and cerebral microcirculation in sheep suffering from ALI and septic shock by reduction of cardiac MDA and 3-nitrotyrosine. BioMed Central 2010 2010-11-26 /pmc/articles/PMC3220026/ /pubmed/21110850 http://dx.doi.org/10.1186/cc9342 Text en Copyright ©2010 Maybauer et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Maybauer, Marc O Maybauer, Dirk M Fraser, John F Szabo, Csaba Westphal, Martin Kiss, Levente Horvath, Eszter M Nakano, Yoshimitsu Herndon, David N Traber, Lillian D Traber, Daniel L Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock |
title | Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock |
title_full | Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock |
title_fullStr | Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock |
title_full_unstemmed | Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock |
title_short | Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock |
title_sort | recombinant human activated protein c attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220026/ https://www.ncbi.nlm.nih.gov/pubmed/21110850 http://dx.doi.org/10.1186/cc9342 |
work_keys_str_mv | AT maybauermarco recombinanthumanactivatedproteincattenuatescardiovascularandmicrocirculatorydysfunctioninacutelunginjuryandsepticshock AT maybauerdirkm recombinanthumanactivatedproteincattenuatescardiovascularandmicrocirculatorydysfunctioninacutelunginjuryandsepticshock AT fraserjohnf recombinanthumanactivatedproteincattenuatescardiovascularandmicrocirculatorydysfunctioninacutelunginjuryandsepticshock AT szabocsaba recombinanthumanactivatedproteincattenuatescardiovascularandmicrocirculatorydysfunctioninacutelunginjuryandsepticshock AT westphalmartin recombinanthumanactivatedproteincattenuatescardiovascularandmicrocirculatorydysfunctioninacutelunginjuryandsepticshock AT kisslevente recombinanthumanactivatedproteincattenuatescardiovascularandmicrocirculatorydysfunctioninacutelunginjuryandsepticshock AT horvatheszterm recombinanthumanactivatedproteincattenuatescardiovascularandmicrocirculatorydysfunctioninacutelunginjuryandsepticshock AT nakanoyoshimitsu recombinanthumanactivatedproteincattenuatescardiovascularandmicrocirculatorydysfunctioninacutelunginjuryandsepticshock AT herndondavidn recombinanthumanactivatedproteincattenuatescardiovascularandmicrocirculatorydysfunctioninacutelunginjuryandsepticshock AT traberlilliand recombinanthumanactivatedproteincattenuatescardiovascularandmicrocirculatorydysfunctioninacutelunginjuryandsepticshock AT traberdaniell recombinanthumanactivatedproteincattenuatescardiovascularandmicrocirculatorydysfunctioninacutelunginjuryandsepticshock |